JPWO2023074794A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023074794A5
JPWO2023074794A5 JP2023556633A JP2023556633A JPWO2023074794A5 JP WO2023074794 A5 JPWO2023074794 A5 JP WO2023074794A5 JP 2023556633 A JP2023556633 A JP 2023556633A JP 2023556633 A JP2023556633 A JP 2023556633A JP WO2023074794 A5 JPWO2023074794 A5 JP WO2023074794A5
Authority
JP
Japan
Prior art keywords
composition
subject
diabetes
insulin
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556633A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023074794A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/040140 external-priority patent/WO2023074794A1/ja
Publication of JPWO2023074794A1 publication Critical patent/JPWO2023074794A1/ja
Publication of JPWO2023074794A5 publication Critical patent/JPWO2023074794A5/ja
Pending legal-status Critical Current

Links

JP2023556633A 2021-10-29 2022-10-27 Pending JPWO2023074794A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021177845 2021-10-29
PCT/JP2022/040140 WO2023074794A1 (ja) 2021-10-29 2022-10-27 Hdac調節剤による糖尿病ならびに合併症の治療方法または治療剤

Publications (2)

Publication Number Publication Date
JPWO2023074794A1 JPWO2023074794A1 (https=) 2023-05-04
JPWO2023074794A5 true JPWO2023074794A5 (https=) 2024-10-18

Family

ID=86159956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556633A Pending JPWO2023074794A1 (https=) 2021-10-29 2022-10-27

Country Status (7)

Country Link
EP (1) EP4424327A4 (https=)
JP (1) JPWO2023074794A1 (https=)
KR (1) KR20240093575A (https=)
CN (1) CN118475370A (https=)
AU (1) AU2022376087A1 (https=)
IL (1) IL312393A (https=)
WO (1) WO2023074794A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220403032A1 (en) * 2019-10-18 2022-12-22 BioZipcode, Inc. Therapy for diabetes using stem cell migration agent
JP2021177845A (ja) 2020-05-12 2021-11-18 株式会社サンセイアールアンドディ 遊技機
US20240139129A1 (en) * 2021-02-26 2024-05-02 BioZipcode, Inc. Novel method and agent for treating, diagnosing and detecting diabetes and complications

Similar Documents

Publication Publication Date Title
Datta et al. Medical and surgical care of critical burn patients: a comprehensive review of current evidence and practice
Forsyth et al. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs
WO2011147584A1 (en) Compositions for use in genetic disorders causative for cystic fibrosis comprising 4-phenyl-butyric acid and its salts
Pituch et al. Butyric acid in functional constipation
Steiropoulos et al. Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control?
Lee et al. Baclofen intoxication: report of four cases and review of the literature
ME02015B (me) Farmaceutski preparati sa (1S)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi- 4-metilfenil]-1-tio-D-glucitolom i sekretagogom insulina
JP2009539862A5 (https=)
CA3072092A1 (en) Branched-chain amino acids for the treatment of neuronal injury
WO2005049006A1 (ja) 糖尿病治療剤
JPWO2023074794A5 (https=)
Boivin et al. The effects of L‐dopa on excessive daytime sleepiness in narcolepsy
JP5403935B2 (ja) 経口用の慢性疼痛予防または治療剤
JPWO2021075536A5 (https=)
JPWO2022181797A5 (https=)
DK2640364T3 (en) Pharmaceutical composition with bicarbonate salt and its use as a drug in the treatment and / or prevention of urolithiasis and associated diseases
Muñiz Valproic acid overdose review of a case with electrocardiographic changes
Toy et al. Corticosteroid, platelet-rich plasma, and ozone injections for sinus tarsi syndrome
JP6100510B2 (ja) 抗感冒剤
Satam et al. Fatal thyrotoxic periodic paralysis with normokalemia
DK2564840T3 (en) Compositions for symptomatic relief of abdominal pain or gastroesophageal reflux
EP4353241A1 (en) Fine silicon particle-containing preventive or therapeutic agent for diseases
Karateev Non-steroidal anti-inflammatory drugs use in clinical practice: new opportunities
Darma et al. Comparative Analysis of Gastric Mucosal damage in Wistar Rats Subjected to Varying Doses of Ibuprofen
Sheehy et al. Apathetic thyrotoxicosis causing gastrointestinal malabsorption